Global and United States Porphyrias Drugs Market Report & Forecast 2024-2031

Report ID: 1825653 | Published Date: Jan 2025 | No. of Page: 72 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Porphyrias Drugs Product Introduction
    1.2 Global Porphyrias Drugs Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Porphyrias Drugs Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Porphyrias Drugs Sales in Volume for the Year 2017-2028
    1.3 United States Porphyrias Drugs Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Porphyrias Drugs Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Porphyrias Drugs Sales in Volume for the Year 2017-2028
    1.4 Porphyrias Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Porphyrias Drugs in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Porphyrias Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Porphyrias Drugs Market Dynamics
        1.5.1 Porphyrias Drugs Industry Trends
        1.5.2 Porphyrias Drugs Market Drivers
        1.5.3 Porphyrias Drugs Market Challenges
        1.5.4 Porphyrias Drugs Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Porphyrias Drugs Market Segment by Type
        2.1.1 Oral
        2.1.2 Injectable
    2.2 Global Porphyrias Drugs Market Size by Type
        2.2.1 Global Porphyrias Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Porphyrias Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Porphyrias Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Porphyrias Drugs Market Size by Type
        2.3.1 United States Porphyrias Drugs Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Porphyrias Drugs Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Porphyrias Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Porphyrias Drugs Market Segment by Application
        3.1.1 Hospital Pharmacies
        3.1.2 Retail Pharmacies
        3.1.3 Online Pharmacies
    3.2 Global Porphyrias Drugs Market Size by Application
        3.2.1 Global Porphyrias Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Porphyrias Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Porphyrias Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Porphyrias Drugs Market Size by Application
        3.3.1 United States Porphyrias Drugs Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Porphyrias Drugs Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Porphyrias Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Porphyrias Drugs Competitor Landscape by Company
    4.1 Global Porphyrias Drugs Market Size by Company
        4.1.1 Top Global Porphyrias Drugs Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Porphyrias Drugs Revenue by Manufacturer (2017-2022)
        4.1.3 Global Porphyrias Drugs Sales by Manufacturer (2017-2022)
        4.1.4 Global Porphyrias Drugs Price by Manufacturer (2017-2022)
    4.2 Global Porphyrias Drugs Concentration Ratio (CR)
        4.2.1 Porphyrias Drugs Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Porphyrias Drugs in 2021
        4.2.3 Global Porphyrias Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Porphyrias Drugs Manufacturing Base Distribution, Product Type
        4.3.1 Global Porphyrias Drugs Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Porphyrias Drugs Product Type
        4.3.3 Date of International Manufacturers Enter into Porphyrias Drugs Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Porphyrias Drugs Market Size by Company
        4.5.1 Top Porphyrias Drugs Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Porphyrias Drugs Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Porphyrias Drugs Sales by Players (2020, 2021 & 2022)
5 Global Porphyrias Drugs Market Size by Region
    5.1 Global Porphyrias Drugs Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Porphyrias Drugs Market Size in Volume by Region (2017-2028)
        5.2.1 Global Porphyrias Drugs Sales in Volume by Region: 2017-2022
        5.2.2 Global Porphyrias Drugs Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Porphyrias Drugs Market Size in Value by Region (2017-2028)
        5.3.1 Global Porphyrias Drugs Sales in Value by Region: 2017-2022
        5.3.2 Global Porphyrias Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Porphyrias Drugs Market Size YoY Growth 2017-2028
        6.1.2 North America Porphyrias Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Porphyrias Drugs Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Porphyrias Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Porphyrias Drugs Market Size YoY Growth 2017-2028
        6.3.2 Europe Porphyrias Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Porphyrias Drugs Market Size YoY Growth 2017-2028
        6.4.2 Latin America Porphyrias Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Porphyrias Drugs Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Porphyrias Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Lundbeck
        7.1.1 Lundbeck Corporation Information
        7.1.2 Lundbeck Description and Business Overview
        7.1.3 Lundbeck Porphyrias Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Lundbeck Porphyrias Drugs Products Offered
        7.1.5 Lundbeck Recent Development
    7.2 Recordati Rare Diseases
        7.2.1 Recordati Rare Diseases Corporation Information
        7.2.2 Recordati Rare Diseases Description and Business Overview
        7.2.3 Recordati Rare Diseases Porphyrias Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Recordati Rare Diseases Porphyrias Drugs Products Offered
        7.2.5 Recordati Rare Diseases Recent Development
    7.3 Teva Pharmaceutical
        7.3.1 Teva Pharmaceutical Corporation Information
        7.3.2 Teva Pharmaceutical Description and Business Overview
        7.3.3 Teva Pharmaceutical Porphyrias Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Teva Pharmaceutical Porphyrias Drugs Products Offered
        7.3.5 Teva Pharmaceutical Recent Development
    7.4 Apotex
        7.4.1 Apotex Corporation Information
        7.4.2 Apotex Description and Business Overview
        7.4.3 Apotex Porphyrias Drugs Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Apotex Porphyrias Drugs Products Offered
        7.4.5 Apotex Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Porphyrias Drugs Industry Chain Analysis
    8.2 Porphyrias Drugs Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Porphyrias Drugs Distributors
    8.3 Porphyrias Drugs Production Mode & Process
    8.4 Porphyrias Drugs Sales and Marketing
        8.4.1 Porphyrias Drugs Sales Channels
        8.4.2 Porphyrias Drugs Distributors
    8.5 Porphyrias Drugs Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Porphyrias Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Porphyrias Drugs Market Trends
    Table 3. Porphyrias Drugs Market Drivers
    Table 4. Porphyrias Drugs Market Challenges
    Table 5. Porphyrias Drugs Market Restraints
    Table 6. Global Porphyrias Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Porphyrias Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Porphyrias Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Porphyrias Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Porphyrias Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Porphyrias Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Porphyrias Drugs Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Porphyrias Drugs Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Porphyrias Drugs Sales Share by Manufacturer, 2017-2022
    Table 15. Global Porphyrias Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Porphyrias Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Porphyrias Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Porphyrias Drugs as of 2021)
    Table 18. Top Players of Porphyrias Drugs in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Porphyrias Drugs Product Type
    Table 20. Date of International Manufacturers Enter into Porphyrias Drugs Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Porphyrias Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Porphyrias Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Porphyrias Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Porphyrias Drugs Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Porphyrias Drugs Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Porphyrias Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Porphyrias Drugs Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Porphyrias Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Porphyrias Drugs Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Porphyrias Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Porphyrias Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Porphyrias Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Porphyrias Drugs Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Porphyrias Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Porphyrias Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Porphyrias Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Porphyrias Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Porphyrias Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Porphyrias Drugs Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Porphyrias Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Lundbeck Corporation Information
    Table 43. Lundbeck Description and Business Overview
    Table 44. Lundbeck Porphyrias Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Lundbeck Porphyrias Drugs Product
    Table 46. Lundbeck Recent Development
    Table 47. Recordati Rare Diseases Corporation Information
    Table 48. Recordati Rare Diseases Description and Business Overview
    Table 49. Recordati Rare Diseases Porphyrias Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Recordati Rare Diseases Product
    Table 51. Recordati Rare Diseases Recent Development
    Table 52. Teva Pharmaceutical Corporation Information
    Table 53. Teva Pharmaceutical Description and Business Overview
    Table 54. Teva Pharmaceutical Porphyrias Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Teva Pharmaceutical Product
    Table 56. Teva Pharmaceutical Recent Development
    Table 57. Apotex Corporation Information
    Table 58. Apotex Description and Business Overview
    Table 59. Apotex Porphyrias Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Apotex Product
    Table 61. Apotex Recent Development
    Table 62. Key Raw Materials Lists
    Table 63. Raw Materials Key Suppliers Lists
    Table 64. Porphyrias Drugs Customers List
    Table 65. Porphyrias Drugs Distributors List
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Porphyrias Drugs Product Picture
    Figure 2. Global Porphyrias Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Porphyrias Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. Global Porphyrias Drugs Sales 2017-2028 (K Units)
    Figure 5. United States Porphyrias Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Porphyrias Drugs Market Size 2017-2028 (US$ Million)
    Figure 7. United States Porphyrias Drugs Sales 2017-2028 (K Units)
    Figure 8. United States Porphyrias Drugs Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Porphyrias Drugs Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Porphyrias Drugs Report Years Considered
    Figure 11. Product Picture of Oral
    Figure 12. Product Picture of Injectable
    Figure 13. Global Porphyrias Drugs Market Share by Type in 2022 & 2028
    Figure 14. Global Porphyrias Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 15. Global Porphyrias Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 16. Global Porphyrias Drugs Sales by Type (2017-2028) & (K Units)
    Figure 17. Global Porphyrias Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 18. Global Porphyrias Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 19. United States Porphyrias Drugs Market Share by Type in 2022 & 2028
    Figure 20. United States Porphyrias Drugs Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 21. United States Porphyrias Drugs Sales Market Share in Value by Type (2017-2028)
    Figure 22. United States Porphyrias Drugs Sales by Type (2017-2028) & (K Units)
    Figure 23. United States Porphyrias Drugs Sales Market Share in Volume by Type (2017-2028)
    Figure 24. United States Porphyrias Drugs Price by Type (2017-2028) & (USD/Unit)
    Figure 25. Product Picture of Hospital Pharmacies
    Figure 26. Product Picture of Retail Pharmacies
    Figure 27. Product Picture of Online Pharmacies
    Figure 28. Global Porphyrias Drugs Market Share by Application in 2022 & 2028
    Figure 29. Global Porphyrias Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Porphyrias Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Porphyrias Drugs Sales by Application (2017-2028) & (K Units)
    Figure 32. Global Porphyrias Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Porphyrias Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 34. United States Porphyrias Drugs Market Share by Application in 2022 & 2028
    Figure 35. United States Porphyrias Drugs Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Porphyrias Drugs Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Porphyrias Drugs Sales by Application (2017-2028) & (K Units)
    Figure 38. United States Porphyrias Drugs Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Porphyrias Drugs Price by Application (2017-2028) & (USD/Unit)
    Figure 40. North America Porphyrias Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 41. North America Porphyrias Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. U.S. Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Europe Porphyrias Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 45. Europe Porphyrias Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 46. Germany Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 47. France Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. U.K. Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Italy Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Russia Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Asia-Pacific Porphyrias Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 52. Asia-Pacific Porphyrias Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 53. China Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Japan Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. South Korea Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. India Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Australia Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Taiwan Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Porphyrias Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 64. Latin America Porphyrias Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Middle East & Africa Porphyrias Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 69. Middle East & Africa Porphyrias Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 70. Turkey Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. Saudi Arabia Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. U.A.E Porphyrias Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Porphyrias Drugs Value Chain
    Figure 74. Porphyrias Drugs Production Process
    Figure 75. Channels of Distribution
    Figure 76. Distributors Profiles
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex
Frequently Asked Questions
Porphyrias Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Porphyrias Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Porphyrias Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Vertigo Treatments

Vertigo Treatments market is segmented by region (country), players, by Type and by Application.  ... Read More